Volume 54, Issue 7, 1 April 2012
1 April News
1 April News
In the Literature
In the Literature
Crossing Borders: One World, Global Health
Crossing Borders: One World, Global Health
ARTICLES AND COMMENTARIES
Prevention of Recurrent High-Grade Anal Neoplasia With Quadrivalent Human Papillomavirus Vaccination of Men Who Have Sex With Men: A Nonconcurrent Cohort Study
Randomized controlled trials demonstrated the efficacy of quadrivalent human papillomavirus (qHPV) in primary prevention of human papillomavirus (HPV) infection and HPV-related cancers/precancerous lesions. Our study suggests that qHPV may be effective in prevention of recurrent high-grade anal neoplasia among men who have sex with men.
The Frequency of Autoimmune N-Methyl-D-Aspartate Receptor Encephalitis Surpasses That of Individual Viral Etiologies in Young Individuals Enrolled in the California Encephalitis Project
Anti-N-methyl-D-aspartic acid receptor encephalitis rivals viral etiologies as a cause of encephalitis within the California Encephalitis Project cohort. Thus it merits a prominent place on the differential diagnosis of encephalitis, allowing for prompt treatment and recovery.
Role of Neutralizing Antibodies in Adults With Community-Acquired Pneumonia by Respiratory Syncytial Virus
In a study of 356 adults with community-acquired pneumonia, respiratory syncytial virus was a frequent pathogen (13%). Serology and real-time reverse-transcription polymerase chain reaction improved the detection of repiratory syncytial virus. High respiratory syncytial virus serum-neutralizing antibody levels protected against severe pneumonia.
Administration of Voriconazole in Patients With Renal Dysfunction
Administration of intravenous voriconazole to patients with creatinine clearance <50 mL/minute for at least 3 days did not affect renal function. Underlying disease, baseline liver impairment, and other drugs (penicillins, fluoroquinolones, pressors, immunosuppressants) were the strongest predictors of renal dysfunction.
Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50–59 Years
In subjects aged 50–59 years, the zoster vaccine (ZV) significantly reduced the incidence of herpes zoster (ZV: 1.99/1000 person-years; placebo: 6.57/1000 person-years) and was well tolerated.
Herpes Zoster Vaccination in People Aged 50–59 Years
Nosocomial Transmission of Norovirus Is Mainly Caused by Symptomatic Cases
Enhanced sampling yielded a 232% increase of identified shedders. Here, symptomatic patients and healthcare workers (HCWs) were more often involved in transmission events than asymptomatic shedders. Asymptomatic HCWs rarely contributed to transmission, despite high levels of fecal virus shedding.
A Comparison of 2 Strategies to Prevent Infection Following Pertussis Exposure in Vaccinated Healthcare Personnel
In this randomized, open-label trial of healthcare personnel previously vaccinated with acellular pertussis vaccine, noninferiority of daily symptom monitoring without postexposure prophylaxis (PEP) compared with antibiotic PEP was not demonstrated for preventing infection following pertussis exposure.
A Cell Culture–Derived Influenza Vaccine Provides Consistent Protection Against Infection and Reduces the Duration and Severity of Disease in Infected Individuals
A Vero cell culture–derived seasonal influenza vaccine provides consistently high levels of protection against cell culture–confirmed infection over a complete influenza season. Influenza symptoms are also less severe and of shorter duration in individuals who become infected despite vaccination.
High-Resolution Single Nucleotide Polymorphism Analysis Distinguishes Recrudescence and Reinfection in Recurrent Invasive Nontyphoidal Salmonella Typhimurium Disease
Invasive nontyphoidal Salmonella Typhimurium disease is a common and frequently recurrent cause of bacteremia across sub-Saharan Africa. We use high-resolution single nucleotide polymorphism analysis to distinguish between reinfection and recrudescence in disease recurrence within single individuals over time.
BRIEF REPORTS
Detection of Human Bocavirus in the Cerebrospinal Fluid of Children With Encephalitis
Tuberculin Skin Test Reactivity Is Dependent on Host Genetic Background in Colombian Tuberculosis Household Contacts
PHOTO QUIZ
A 32-Year-Old Man With Ulcerative Mucositis, Skin Lesions, and Nail Dystrophy
INVITED ARTICLES
AGING AND INFECTIOUS DISEASES
Diagnostic Challenges and Opportunities in Older Adults With Infectious Diseases
HIV/AIDS
Provisional Guidance on the Use of Hepatitis C Virus Protease Inhibitors for Treatment of Hepatitis C in HIV-Infected Persons
HIV/AIDS
Does an Index Composed of Clinical Data Reflect Effects of Inflammation, Coagulation, and Monocyte Activation on Mortality Among Those Aging With HIV?
The Veterans Aging Cohort Study (VACS) Index, based on age and 8 routine clinical tests, is strongly correlated with 3 biomarkers of inflammation: interleukin 6 (IL-6), D-dimer, and soluble CD14 (sCD14). After adjustment for the VACS Index, D-dimer and sCD14, but not IL-6, remain independently associated with mortality.
Viremia and HIV-1 Drug Resistance Mutations Among Patients Receiving Second-Line Highly Active Antiretroviral Therapy in Chennai, Southern India
Analysis of human immunodeficiency virus type 1 pol gene sequences from 107 patients receiving second-line antiretroviral therapy (ART) revealed that a high prevalence of resistance mutations among second-line ART-experienced patients limits the ART-sequencing options, suggesting darunavir as the third-line drug in India.
Neurocognitive and Motor Deficits in HIV-Infected Ugandan Children With High CD4 Cell Counts
Human immunodeficiency virus (HIV)-infected antiretroviral therapy-naive Ugandan children with CD4 cell counts of ∼350 cells/μL and percentages of >15% have significant motor and cognitive deficits compared with HIV-uninfected children. Study of whether early initiation of treatment could prevent or reverse such deficits is needed.
Yet Another Reason to Treat HIV Infection
Vitamin D3 Decreases Parathyroid Hormone in HIV-Infected Youth Being Treated With Tenofovir: A Randomized, Placebo-Controlled Trial
In this randomized, double-blind, placebo-controlled trial of human immunodeficiency virus–infected youths aged 18–25, vitamin D3, 50000 IU once monthly for 3 months decreased parathyroid hormone in participants treated with tenofovir-containing antiretroviral regimens but not in those participants whose regimens did not contain tenofovir.
Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America
In a large North American cohort study, anal cancer incidence rates were substantially higher for HIV-infected men who have sex with men, other men, and women compared with HIV-uninfected individuals. Rates increased from 1996–1999 to 2000–2003 but plateaued by 2004–2007.
ANSWER TO THE PHOTO QUIZ
A 32-Year-Old Man With Ulcerative Mucositis, Skin Lesions, and Nail Dystrophy
CORRESPONDENCE
Predictors of Serological Cure After Treatment of Early Syphilis
Reply to Keynan
Letter re: Marr editorial
ERRATUM
Erratum
ELECTRONIC ARTICLES
Toxoplasmosis Hospitalizations in the United States, 2008, and Trends, 1993–2008
Although numbers of toxoplasmosis-related hospitalizations in the United States have declined since the mid-1990s, there continue to be many such hospitalizations (>3500 estimated in 2008), especially among human immunodeficiency virus–infected persons and those in racial or ethnic minority groups.
A Cluster of Pneumocystis Infections Among Renal Transplant Recipients: Molecular Evidence of Colonized Patients as Potential Infectious Sources of Pneumocystis jirovecii
An outbreak of Pneumocystis jirovecii infections in renal transplant recipients was investigated using P. jirovecii type identification combined with analysis of patient encounters. The results suggest that colonized patients represent infectious sources in a context of nosocomial acquisition of the fungus.